Cargando…

Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial

OBJECTIVE: To determine the efficacy and safety of dalteparin postoperative bridging treatment versus placebo for patients with atrial fibrillation or mechanical heart valves when warfarin is temporarily interrupted for a planned procedure. DESIGN: Prospective, double blind, randomised controlled tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kovacs, Michael J, Wells, Philip S, Anderson, David R, Lazo-Langner, Alejandro, Kearon, Clive, Bates, Shannon M, Blostein, Mark, Kahn, Susan R, Schulman, Sam, Sabri, Elham, Solymoss, Susan, Ramsay, Tim, Yeo, Erik, Rodger, Marc A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188228/ https://www.ncbi.nlm.nih.gov/pubmed/34108229 http://dx.doi.org/10.1136/bmj.n1205

Ejemplares similares

Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
por: Wells, Philip S., et al.
Publicado: (2022)

Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis
por: Khan, Faizan, et al.
Publicado: (2017)

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
por: Khan, Faizan, et al.
Publicado: (2019)

Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants’ data from seven trials
por: Boutitie, Florent, et al.
Publicado: (2011)

Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis
por: Lopes, Luciane Cruz, et al.
Publicado: (2014)

Diagnosis of deep vein thrombosis with D-dimer adjusted to clinical probability: prospective diagnostic management study
por: Kearon, Clive, et al.
Publicado: (2022)

Normal levels of protein C and protein S tested in the acute phase of a venous thromboembolic event are not falsely elevated
por: Minuk, Leonard, et al.
Publicado: (2010)

MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial
por: Galanaud, Jean Philippe, et al.
Publicado: (2021)

Comparing multiple competing interventions in the absence of randomized trials using clinical risk-benefit analysis
por: Lazo-Langner, Alejandro, et al.
Publicado: (2012)

Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study
por: Rodger, Marc A, et al.
Publicado: (2017)

Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome
por: Legault, Kimberly, et al.
Publicado: (2020)

Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding
por: Nagata, Naoyoshi, et al.
Publicado: (2017)

Relevance of Non-Bridging Therapy with Heparin during Temporary Interruption of Direct Oral Anticoagulants in Patients with Cancer-Associated Venous Thromboembolism
por: Oyakawa, Takuya, et al.
Publicado: (2022)

Venous Thromboembolism in Hospitalized Critical and Noncritical COVID-19 Patients: A Systematic Review and Meta-analysis
por: Mansory, Eman M., et al.
Publicado: (2021)

Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE Study
por: Ma, Kim A., et al.
Publicado: (2018)

Heparin bridge therapy and post-polypectomy bleeding
por: Kubo, Toshiyuki, et al.
Publicado: (2016)

Safety of heparin prophylaxis for venous thromboembolism in patients with neurotrauma
por: Puri, G, et al.
Publicado: (2010)

Low-molecular-weight heparins in the treatment of venous thromboembolism
por: Ageno , Walter, et al.
Publicado: (2000)

A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin
por: Tao, Ende, et al.
Publicado: (2020)

Perioperative thromboembolism prophylaxis in children – is it necessary?
por: Pągowska-Klimek, Izabela
Publicado: (2020)

Risk-adjusted perioperative bridging anticoagulation reduces bleeding complications without increasing thromboembolic events in general and visceral surgery
por: Döhler, Ida, et al.
Publicado: (2023)

Heparin Induced Thrombocytopenia for the Perioperative and Critical Care Clinician
por: Moreno-Duarte, Ingrid, et al.
Publicado: (2020)

Immigration, region of origin, and the epidemiology of venous thromboembolism: A population‐based study
por: Lazo‐Langner, Alejandro, et al.
Publicado: (2018)

Why differentiate low molecular weight heparins for venous thromboembolism?
por: Fareed, Jawed, et al.
Publicado: (2007)

Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism
por: Smythe, Maureen A., et al.
Publicado: (2016)

Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia
por: Costanzo, Luca, et al.
Publicado: (2020)

Cancer and thrombosis: recent advances
por: Solymoss, S.
Publicado: (2008)

Thromboelastography for the Prevention of Perioperative Venous Thromboembolism in Orthopedics
por: Fan, Dejing, et al.
Publicado: (2022)

The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
por: Spyropoulos, Alex C, et al.
Publicado: (2008)

Management of venous thromboembolism: an update
por: Piran, Siavash, et al.
Publicado: (2016)

A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome
por: Legault, Kimberly, et al.
Publicado: (2020)

Thromboembolic and major bleeding events in relation to perioperative bridging of vitamin K antagonists in 649 fast-track total hip and knee arthroplasties
por: Jørgensen, Christoffer C, et al.
Publicado: (2017)

Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Unfractionated heparin or low-molecular-weight heparin for venous thromboembolism prophylaxis after hepatic resection: A meta-analysis
por: Zhang, Wentao, et al.
Publicado: (2022)

Guidance for the treatment and prevention of obstetric-associated venous thromboembolism
por: Bates, Shannon M., et al.
Publicado: (2016)

Predicting Perioperative Venous Thromboembolism in Japanese Gynecological Patients
por: Ikeda, Masae, et al.
Publicado: (2014)

Influence of Tobacco Smoking on Perioperative Risk of Venous Thromboembolism
por: Al-Nasser, Bassam
Publicado: (2020)

Respiratory Review of 2013: Pulmonary Thromboembolism
por: Hwang, Hun Gyu, et al.
Publicado: (2013)

Spontaneous Heparin-Induced Thrombocytopenia and Venous Thromboembolism following Total Knee Arthroplasty
por: Baker, Kevin, et al.
Publicado: (2017)

Multicenter study on hemorrhagic risk of heparin bridging therapy for periendoscopic thromboprophylaxis
por: Matsumoto, Mio, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ao1uhktmaij5811ts7h0hrd9na